United Kingdom

People: Cryoport Inc (CYRX.OQ)

CYRX.OQ on NASDAQ Stock Exchange Capital Market

8:00pm GMT
Change (% chg)

$-0.36 (-3.60%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Berman, Richard 

Mr. Richard J. Berman, J.D. is the Independent Director of the Company. He serve as Chairman of the Audit and Compensation Committee and member of the Nominating and Governance Committee of the Board. Mr. Berman’s business career consists of more than 35 years of venture capital, management and merger and acquisitions experience. He currently serves as a director of four public companies: NeoStem, Inc. (NASDAQ: NBS), Advaxis, Inc. (OTC: ADXS), Lustros, Inc. (OTC: LSLD) and MetaStat Inc. (OTC: MTST), where he is the chairman, and has served as a director and/or officer of more than a dozen public and private companies. His previous experience includes positions at Goldman Sachs and as Senior Vice President of Bankers Trust Company. Some of his more notable positions include his service from 2006-2011 as Chairman of National Investment Managers (OTC: NIVM.OB), a company with $12 billion in pension administration assets. In 2012, he sold Easylink Services for over $300 million, where he was chairman and CEO from 1999 to 2000 and director from 1998 to 2012. From 2004-2010, Mr. Berman served as a Director of NexMed Inc., a public biotech company. In 2008, Mr. Berman became its Chairman and CEO. In 2010 he merged the company with Apricus Biosciences. Mr. Berman is a past director of the Stern School of Business of NYU, where he received his B.S. and M.B.A. He also holds two law degrees, a J.D. from Boston College and a Special Certificate from The Hague Academy of International Law.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --